Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
24.97
+0.01 (0.04%)
At close: Mar 6, 2026
SHE:002287 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | - | 189.59 | 403.43 | 437.57 | 666.63 |
Short-Term Investments | - | - | - | 224.65 | 107.74 |
Trading Asset Securities | - | 2,807 | 1,963 | 1,539 | 1,184 |
Cash & Short-Term Investments | 3,022 | 2,997 | 2,366 | 2,202 | 1,958 |
Cash Growth | 0.84% | 26.64% | 7.49% | 12.42% | 6.98% |
Accounts Receivable | - | 942.91 | 604.86 | 825.39 | 606.61 |
Other Receivables | - | 6.18 | 18.34 | 10.03 | 212.89 |
Receivables | - | 949.09 | 623.19 | 835.42 | 819.49 |
Inventory | - | 185.33 | 156.33 | 127.77 | 118.5 |
Prepaid Expenses | - | 0.09 | 1.11 | 6.88 | 1.99 |
Other Current Assets | - | 22.9 | 47.25 | 20.83 | 38.07 |
Total Current Assets | - | 4,154 | 3,194 | 3,192 | 2,936 |
Property, Plant & Equipment | - | 1,695 | 1,647 | 1,144 | 821.35 |
Long-Term Investments | - | 561.24 | 1,043 | 1,116 | 1,357 |
Other Intangible Assets | - | 325.5 | 351.62 | 374.81 | 399.33 |
Long-Term Deferred Tax Assets | - | 36.02 | 39.39 | 30.59 | 26.68 |
Long-Term Deferred Charges | - | 3.92 | 4.95 | 3.29 | 5.25 |
Other Long-Term Assets | - | 14.79 | 17.68 | 26.33 | 21.28 |
Total Assets | - | 6,790 | 6,298 | 5,888 | 5,568 |
Accounts Payable | - | 235.44 | 266.23 | 93.47 | 184 |
Accrued Expenses | - | 366.76 | 352.86 | 330.7 | 297.27 |
Short-Term Debt | - | 813.01 | 451.52 | 701.73 | 501.81 |
Current Portion of Long-Term Debt | - | 80.28 | 9.02 | 54.11 | 103.93 |
Current Portion of Leases | - | 5.34 | 6.39 | 6.47 | 5.07 |
Current Income Taxes Payable | - | 18.8 | 55.56 | 25.9 | 9.83 |
Current Unearned Revenue | - | 110.02 | 73.89 | 102.16 | 110.11 |
Other Current Liabilities | - | 34.97 | 29.74 | 45.59 | 95.96 |
Total Current Liabilities | - | 1,665 | 1,245 | 1,360 | 1,308 |
Long-Term Debt | - | 797.8 | 1,061 | 929.47 | 836.48 |
Long-Term Leases | - | 1.68 | 7 | 4.91 | 4.94 |
Long-Term Unearned Revenue | - | 184.14 | 191.3 | 167.04 | 154.66 |
Long-Term Deferred Tax Liabilities | - | 26.28 | 20.94 | 36.39 | 40.71 |
Other Long-Term Liabilities | - | 2.6 | 2.6 | 2.6 | 2.6 |
Total Liabilities | - | 2,677 | 2,528 | 2,501 | 2,347 |
Common Stock | - | 531.09 | 530.19 | 530.22 | 530.3 |
Additional Paid-In Capital | - | 495.02 | 477.25 | 476.33 | 480.44 |
Retained Earnings | - | 2,904 | 2,576 | 2,202 | 2,042 |
Treasury Stock | - | - | -0.48 | -8.68 | -16.97 |
Comprehensive Income & Other | - | 134.35 | 137.25 | 136.4 | 133.14 |
Total Common Equity | 4,802 | 4,064 | 3,720 | 3,336 | 3,169 |
Minority Interest | - | 48.94 | 49.82 | 51.64 | 51.35 |
Shareholders' Equity | 4,851 | 4,113 | 3,770 | 3,388 | 3,220 |
Total Liabilities & Equity | - | 6,790 | 6,298 | 5,888 | 5,568 |
Total Debt | 987.2 | 1,698 | 1,535 | 1,697 | 1,452 |
Net Cash (Debt) | 2,035 | 1,299 | 831.28 | 504.82 | 506.11 |
Net Cash Growth | 56.68% | 56.24% | 64.67% | -0.26% | -18.75% |
Net Cash Per Share | 3.74 | 2.45 | 1.57 | 0.95 | 0.96 |
Filing Date Shares Outstanding | 568.35 | 530.03 | 530.19 | 529.64 | 528.63 |
Total Common Shares Outstanding | 569.44 | 531.09 | 530.19 | 529.64 | 528.63 |
Working Capital | - | 2,490 | 1,949 | 1,832 | 1,628 |
Book Value Per Share | 8.43 | 7.65 | 7.02 | 6.30 | 5.99 |
Tangible Book Value | 4,495 | 3,739 | 3,369 | 2,961 | 2,770 |
Tangible Book Value Per Share | 7.89 | 7.04 | 6.35 | 5.59 | 5.24 |
Buildings | - | 1,356 | 1,309 | 705.16 | 671.59 |
Machinery | - | 425.39 | 328.81 | 190.32 | 181.58 |
Construction In Progress | - | 294.56 | 302.75 | 533.08 | 212.04 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.